WordNet

7th president of the US; successfully defended New Orleans from the British in 1815; expanded the power of the presidency (1767-1845) (同)Andrew Jackson, Old Hickory
English film actress who later became a member of British Parliament (born in 1936) (同)Glenda Jackson
United States writer of romantic novels about the unjust treatment of Native Americans (1830-1885) (同)Helen Hunt Jackson, Helen Maria Fiske Hunt Jackson
United States civil rights leader who led a national campaign against racial discrimination and ran for presidential nomination (born in 1941) (同)Jesse Jackson, Jesse Louis Jackson
United States singer who did much to popularize gospel music (1911-1972) (同)Mahalia Jackson
United States singer who began singing with his four brothers and later became a highly successful star during the 1980s (born in 1958) (同)Michael Jackson, Michael Joe Jackson
general in the Confederate Army during the American Civil War whose troops at the first Battle of Bull Run stood like a stone wall (1824-1863) (同)Thomas Jackson, Thomas J. Jackson, Thomas Jonathan Jackson, Stonewall Jackson
capital of the state of Mississippi on the Pearl River (同)capital of Mississippi
a town in south central Michigan
a town in western Tennessee
a town in western Wyoming
a pattern of symptoms indicative of some disease
a complex of concurrent things; "every word has a syndrome of meanings"

PrepTutorEJDIC

(疾患の徴候となる一群の)症徴候,症候群 / (事件・社会的状態などのパターンを示す)徴候形態

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 頚動脈内膜剥離術 carotid endarterectomy
2. 傍神経節腫：疫学、臨床症状、診断、および組織学的検査 paragangliomas epidemiology clinical presentation diagnosis and histology
3. 食道穿孔の外科的マネージメント surgical management of esophageal perforation
4. 頭蓋骨縫合早期癒合症候群 craniosynostosis syndromes
5. 非医原性外傷性食道穿孔のマネージメント management of non iatrogenic traumatic esophageal perforations

English Journal

Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race-ethnicity, and the effect on the prevalence of trisomy 21, Metropolitan Atlanta, 1996-2005.

Jackson JM, Crider KS, Cragan JD, Rasmussen SA, Olney RS.Author information National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.AbstractThe prevalence of trisomy 21 has been reported to differ by race-ethnicity, however, the results are inconsistent and the cause of the differences is unknown. Using data from 1996 to 2005 from the Metropolitan Atlanta Congenital Defects Program (MACDP), we analyzed the use of prenatal cytogenetic testing and the subsequent use of elective termination among pregnancies affected with any MACDP-eligible birth defect and trisomy 21, by maternal race-ethnicity. We then examined whether these factors could explain the observed differences in the prevalence of trisomy 21 among race-ethnicity groups. Among all pregnancies with birth defects, prenatal cytogenetic testing as well as elective terminations after an abnormal prenatal cytogenetic test result were observed less frequently among Hispanic women than among non-Hispanic white women (odds ratio [OR] 0.66, 95% confidence interval [CI] 0.56-0.78, respectively). In pregnancies affected by trisomy 21, both the Hispanic and the non-Hispanic black populations had more live births (89.5% and 77.8%, respectively) and fewer elective terminations (5.7% and 15.2%, respectively) compared to the non-Hispanic white population (63.0% live births, 32.3% elective terminations). After adjusting for elective terminations, non-Hispanic white mothers had a higher live birth prevalence of trisomy 21 compared to non-Hispanic black (OR 0.64, 95% CI 0.54-0.76) or Hispanic mothers (OR 0.69, 95% CI 0.55-0.86). Overall, our data suggest that factors associated with decisions made about the use of prenatal testing, and about pregnancy management after testing, might play a large role in the race-ethnicity differences observed in the live birth prevalence of trisomy 21. © 2013 Wiley Periodicals, Inc.
American journal of medical genetics. Part A.Am J Med Genet A.2014 Jan;164(1):70-6. doi: 10.1002/ajmg.a.36247. Epub 2013 Nov 22.
The prevalence of trisomy 21 has been reported to differ by race-ethnicity, however, the results are inconsistent and the cause of the differences is unknown. Using data from 1996 to 2005 from the Metropolitan Atlanta Congenital Defects Program (MACDP), we analyzed the use of prenatal cytogenetic te
PMID 24273106

Age, body mass, usage of exogenous estrogen, and lifestyle factors in relation to circulating sex hormone-binding globulin concentrations in postmenopausal women.

Goto A, Chen BH, Song Y, Cauley J, Cummings SR, Farhat GN, Gunter M, Van Horn L, Howard BV, Jackson R, Lee J, Rexrode KM, Liu S.Author information Department of Diabetes Research, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan;AbstractBACKGROUND: Circulating concentrations of sex hormone-binding globulin (SHBG) have been associated with cardiovascular diseases, type 2 diabetes, metabolic syndrome, and hormone-dependent cancers; however, correlates of SHBG concentrations are not well understood.
Clinical chemistry.Clin Chem.2014 Jan;60(1):174-85. doi: 10.1373/clinchem.2013.207217. Epub 2013 Sep 18.
BACKGROUND: Circulating concentrations of sex hormone-binding globulin (SHBG) have been associated with cardiovascular diseases, type 2 diabetes, metabolic syndrome, and hormone-dependent cancers; however, correlates of SHBG concentrations are not well understood.METHODS: We comprehensively investig
PMID 24048437

Identification and Quantitation of Biomarkers for Radiation-induced Injury via Mass Spectrometry.

Jones JW, Scott AJ, Tudor G, Xu PT, Jackson IL, Vujaskovic Z, Booth C, Macvittie TJ, Ernst RK, Kane MA.Author information *University of Maryland, School of Pharmacy, Department of Pharmaceutical Sciences, Baltimore, MD; †University of Maryland, School of Dentistry, Department of Microbial Pathogenesis, Baltimore, MD; ‡Epistem Ltd, Manchester, UK; §University of Maryland, School of Medicine, Department of Radiation Oncology, Baltimore, MD.AbstractBiomarker identification and validation for radiation exposure is a rapidly expanding field encompassing the need for well defined animal models and advanced analytical techniques. The resources within the consortium, Medical Countermeasures Against Radiological Threats (MCART), provide a unique opportunity for accessing well defined animal models that simulate the key sequelae of the acute radiation syndrome and the delayed effects of acute radiation exposure. Likewise, the use of mass spectrometry-based analytical techniques for biomarker discovery and validation enables a robust analytical platform that is amenable to a variety of sample matrices and considered the benchmark for biomolecular identification and quantitation. Herein, the authors demonstrate the use of two targeted mass spectrometry approaches to link established MCART animal models to identified metabolite biomarkers. Circulating citrulline concentration was correlated to gross histological gastrointestinal tissue damage, and retinoic acid production in lung tissue was established to be reduced at early and late time points post high dose irradiation. Going forward, the use of mass spectrometry-based metabolomics coupled to well defined animal models provides the unique opportunity for comprehensive biomarker discovery.
Health physics.Health Phys.2014 Jan;106(1):106-19. doi: 10.1097/HP.0b013e3182a4ed3b.
Biomarker identification and validation for radiation exposure is a rapidly expanding field encompassing the need for well defined animal models and advanced analytical techniques. The resources within the consortium, Medical Countermeasures Against Radiological Threats (MCART), provide a unique opp
PMID 24276554